Jade Biosciences Appoints Brad Dahms as Chief Financial Officer
Jade Biosciences Appoints Brad Dahms as Chief Financial Officer GlobeNewswire July 01, 2025 SAN FRANCISCO and VANCOUVER, British Columbia, July 01, 2025 (GLOBE NEWSWIRE) — Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the appointment of Brad Dahms as Chief Financial Officer. “Brad is […]